Mizuho initiated coverage of Veeva (VEEV) with an Outperform rating and $275 price target The firm says Veeva remains the market share leader in life science commercial and development cloud solutions. It expects the company’s mid-teens sales to continue through fiscal 2028, noting the company is only 14% penetrated in its $20B total addressable market. Veeva’s total revenue growth has rebounded this year, as the secular softening of end customer spending has slowly improved, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- VEEV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Options Volatility and Implied Earnings Moves This Week, December 02 – December 05, 2024
- Workday initiated, Kraft Heinz downgraded: Wall Street’s top analyst calls
- Veeva initiated with a Sector Perform at Scotiabank
- Boehringer Ingelheim commits to Veeva Vault CRM